Opportunity
Simpler Grants.gov #PAR-25-079
NCI Seeks Partnerships to Develop and Validate In Vivo Imaging Systems for Cancer Research
Buyer
National Institutes of Health
Posted
November 06, 2024
Respond By
January 07, 2027
Identifier
PAR-25-079
NAICS
541715
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is seeking proposals for academic-industrial partnerships to develop and validate in vivo imaging systems for cancer research. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - Products/Services Requested: - Development and validation of in vivo imaging systems - Focus on innovative imaging, data science, and spectroscopic technologies - Applications should address cancer biology, risk assessment, diagnosis, treatment, or disease status - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named in the solicitation - Unique or Notable Requirements: - Open to a wide range of applicants: government entities, nonprofits, educational institutions, businesses, and other organizations - Emphasis on translating scientific discoveries into practical imaging tools for cancer and related diseases - No cost sharing or matching requirement - Award amount is $500,000 - No specific products, part numbers, or purchase quantities are listed
Description
The National Cancer Institute (NCI) seeks to stimulate the translation of scientific discoveries and engineering developments in imaging, data science, and spectroscopic technologies into methods or tools that address key issues in understanding cancer biology, risk, diagnosis, treatment, and disease status. This funding opportunity supports projects that aim to develop innovative imaging systems for cancer or other diseases. Eligible applicants include a wide range of government entities, nonprofits, educational institutions, businesses, and other organizations. The award amount is $500,000 with no cost sharing required.